Millions of older Americans may have access for the first time to obesity drugs at a low price of $50 a month starting in ...

Learn who qualifies for Medicare’s GLP-1 Bridge, when $50 Wegovy and Zepbound access begins, and key rules beneficiaries need ...

In clinical trials, the drug was shown to almost double the median survival time for patients with pancreatic cancer.

With millions of people now using GLP-1 drugs such as Wegovy and Zepbound, scientists are racing to find ways to help people retain their weight loss after they stop taking the medication ...

GLP‑1 drugs appear to change how much we want to eat, and how strongly food “pulls” on the brain. Newer oral versions may ...

Cantex and Headlamp Health are teaming up to accelerate the development of azeliragon for severe depression and fatigue in MS ...

Learn what really happens to your blood sugar when you add artificial sweeteners to your diet. Discover how they compare to ...